Spin membrane immunoassay for use in meningococcal serology

Area of Science:

• Immunology
• Biochemistry
• Analytical Chemistry

Background:

• Neisseria meningitidis poses a significant public health threat, necessitating reliable methods for assessing immune responses to vaccines.
• Current diagnostic methods for detecting complement-activating antibodies can be complex or lack sensitivity.
• Development of novel immunoassays is crucial for effective vaccine efficacy monitoring.

Purpose of the Study:

• To develop and validate a modified spin membrane immunoassay for detecting complement-activating antibodies against Neisseria meningitidis capsular polysaccharides.
• To evaluate the assay's performance for different serogroups (A, B, and C) and compare its sensitivity to radioimmunoassay.
• To assess the assay's utility in monitoring antibody responses following vaccination.

Main Methods:

• Incorporation of Neisseria meningitidis capsular polysaccharides into large unilamellar vesicles containing the spin label tempocholine chloride.
• Induction of complement-mediated membrane damage by specific antisera, leading to spin label release.
• Quantification of released spin label using electron spin resonance (ESR) spectroscopy.

Main Results:

• A functional spin membrane immunoassay was established for Neisseria meningitidis serogroups A and C polysaccharides.
• The assay demonstrated sensitivity comparable to radioimmunoassay, offering a rapid detection method.
• Analysis of paired sera from recruits vaccinated with A + C polysaccharide vaccine showed significant increases in antibody titers post-vaccination.

Conclusions:

• The developed spin membrane immunoassay is a rapid and sensitive tool for detecting complement-activating antibodies to Neisseria meningitidis.
• This assay shows potential for monitoring the immunogenicity of Neisseria meningitidis polysaccharide vaccines.
• Further optimization may be required for robust detection of antibodies against serogroup B polysaccharides.